These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3668708)

  • 61. Cost benefit of pharmacist concurrent monitoring of cefazolin prescribing.
    Suzuki NT; Pelham LD
    Am J Hosp Pharm; 1983 Jul; 40(7):1187-91. PubMed ID: 6410913
    [No Abstract]   [Full Text] [Related]  

  • 62. Costs are the target at hospital's rounds.
    Stone B
    Am Med News; 1979 Jun; 22(25):1, 13-4. PubMed ID: 10308936
    [No Abstract]   [Full Text] [Related]  

  • 63. A multicenter survey of cefazolin usage.
    Steckel SD; Siskin SB
    Hosp Formul; 1981 Nov; 16(11):1284-6, 1291-3. PubMed ID: 10253176
    [No Abstract]   [Full Text] [Related]  

  • 64. Impact of a hospital formulary on prescribing habits and drug costs.
    Feely J; Chan R; Cocoman L
    Ir Med J; 1987 Oct; 80(10):286-7. PubMed ID: 3692735
    [No Abstract]   [Full Text] [Related]  

  • 65. Impact of a pharmacist/physician cooperative target drug monitoring program on prophylactic antibiotic prescribing in obstetrics and gynecology.
    Michael KA; Henderson PL; Newman RB; Blackwelder EN; Caldwell RD
    Hosp Pharm; 1992 Mar; 27(3):213-6. PubMed ID: 10116721
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Economic grand rounds focus physician attention on how much it costs hospital to treat patients.
    Cost Containment; 1983 Nov; 5(21):1-2. PubMed ID: 10263150
    [No Abstract]   [Full Text] [Related]  

  • 67. Modification of physician behavior by performance feedback.
    Corder MP
    Physician Exec; 1996 Apr; 22(4):26-8. PubMed ID: 10156726
    [No Abstract]   [Full Text] [Related]  

  • 68. Reducing prophylactic antibiotic costs in cardiovascular surgery: the role of the clinical pharmacist.
    Peterson CD; Lake KD
    Drug Intell Clin Pharm; 1986 Feb; 20(2):134-7. PubMed ID: 3948689
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cost containment: a practical approach to physician involvement.
    Chamberlain JO
    OH; 1978 Oct; 22(9):12-3. PubMed ID: 10238535
    [No Abstract]   [Full Text] [Related]  

  • 70. The multiple costs of accountability.
    Nestler WB
    AHME J; 1975; 8(1):12-4. PubMed ID: 10237061
    [No Abstract]   [Full Text] [Related]  

  • 71. Cost ombudsman teaches physicians to break expensive habits.
    Breo DL
    Trustee; 1978 Sep; 31(9):13, 15. PubMed ID: 10238409
    [No Abstract]   [Full Text] [Related]  

  • 72. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing.
    Khanderia U
    Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Economic grand rounds: a forum for cost consciousness.
    Schroeder RE; Acker BJ; Schell MG; Troyer JE; Whitaker NK
    Hosp Health Serv Adm; 1992; 37(4):491-502. PubMed ID: 10171277
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Developing documentation guidelines?
    Koepke M
    J Am Med Rec Assoc; 1985 Feb; 56(2):38-40. PubMed ID: 10310978
    [No Abstract]   [Full Text] [Related]  

  • 75. Physicians' office condos--a unique approach to capital development.
    Roodman RD
    Hosp Financ Manage; 1980 Sep; 34(9):20, 24-6. PubMed ID: 10248663
    [No Abstract]   [Full Text] [Related]  

  • 76. Prophylactic antibiotics in abdominal hysterectomy.
    Tanos V; Rojansky N
    J Am Coll Surg; 1994 Nov; 179(5):593-600. PubMed ID: 7952465
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Physicians' perceptions and knowledge of drug costs: results of a survey.
    Barclay LP; Hatton RC; Doering PL; Shands JW
    Formulary; 1995 May; 30(5):268-70, 272, 277-9. PubMed ID: 10151726
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Formulary decisions concerning cephalosporins.
    Fuentes RJ
    Am J Hosp Pharm; 1979 Mar; 36(3):296, 300. PubMed ID: 420220
    [No Abstract]   [Full Text] [Related]  

  • 79. Cost containment through therapeutic substitution of aminoglycosides.
    Guernsey BG; Berina LF; Lazarus MC; Hokanson JA; Prohaska C; Allen JA; Doutre WH; Mader JT
    Hosp Pharm; 1985 Feb; 20(2):82-3, 86-92, 95. PubMed ID: 10270312
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Cefazolin (Kefzol, Eli Lilly) and Cefazolin (Astra)].
    Kampmann JP
    Ugeskr Laeger; 1975 Jan; 137(5):284. PubMed ID: 1136040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.